Arylamine N-acetyltransferase
From Proteopedia
(Difference between revisions)
| Line 21: | Line 21: | ||
</StructureSection> | </StructureSection> | ||
| - | ==3D structures of arylamine N-acetyltransferase== | ||
| - | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
| - | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
| - | |||
| - | *Arylamine N-acetyltransferase | ||
| - | |||
| - | **[[1gx3]] – MsNAT – ''Mycobacterium smegmatis''<br /> | ||
| - | **[[1w5r]] – MsNAT (mutant)<br /> | ||
| - | **[[2bsz]] – RlNAT1 – ''Rhizobium loti''<br /> | ||
| - | **[[4nv8]] – RlNAT (mutant)<br /> | ||
| - | **[[2ija]] – hNAT1 (mutant) – human<br /> | ||
| - | **[[1w4t]] – NAT – ''Pseudomonas aeruginosa''<br /> | ||
| - | **[[3d9w]] – NAT – ''Nocardia farcinica''<br /> | ||
| - | **[[3lnb]] – NAT (mutant) – ''Bacillus anthracis''<br /> | ||
| - | **[[2vfb]], [[4c5p]] - MmNAT – ''Mycobacterium marinum''<br /> | ||
| - | **[[4bgf]] - NAT – ''Mycobacterium tuberculosis''<br /> | ||
| - | **[[1e2t]] - NAT – ''Salmonella typhimurium''<br /> | ||
| - | |||
| - | *Arylamine N-acetyltransferase binary complex | ||
| - | |||
| - | **[[2pqt]] - hNAT1 + Cys intermediate<br /> | ||
| - | **[[2pfr]] – hNAT2 + CoA<br /> | ||
| - | **[[2vfc]] – MmNAT + CoA<br /> | ||
| - | **[[3ltw]] – MmNAT + hydralazine<br /> | ||
| - | **[[1w6f]] – MsNAT + anti-tubercular drug<br /> | ||
| - | **[[4b55]] – MmNAT + piperidinol derivative<br /> | ||
| - | **[[4nv7]] – RlNAT + CoA<br /> | ||
| - | |||
| - | }} | ||
== References == | == References == | ||
<references/> | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Current revision
| |||||||||||
References
- ↑ Wu H, Dombrovsky L, Tempel W, Martin F, Loppnau P, Goodfellow GH, Grant DM, Plotnikov AN. Structural basis of substrate-binding specificity of human arylamine N-acetyltransferases. J Biol Chem. 2007 Oct 12;282(41):30189-97. Epub 2007 Jul 26. PMID:17656365 doi:10.1074/jbc.M704138200
